Viriya Kaewkangsadan

Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery

Chandan Verma, Viriya Kaewkangsadan, Jennifer Eremin et al. · Journal of Translational Medicine · 2015 · 79 citations · Full text

Life Sciences, Immunology, Oncology +16

Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer

Viriya Kaewkangsadan, Chandan Verma, Jennifer Eremin et al. · Journal of Immunology Research · 2016 · 56 citations · Full text

Life Sciences, Immunology, Oncology +17

The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers

Viriya Kaewkangsadan, Chandan Verma, Jennifer Eremin et al. · Journal of Immunology Research · 2017 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC

Viriya Kaewkangsadan, Chandan Verma, Jennifer Eremin et al. · BMC Cancer · 2018 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting

Xavier Pivot, V.A. Shamrai, Giorgi Dzagnidze et al. · JAMA Oncology · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17